Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ArQule reports phase II data on ARQ-197 in non-small cell lung cancer

April 6, 2010

Auckland Uniservices discovers novel nitrobenzindole prodrugs for treatment of cancer

April 6, 2010

Critical Outcome Technologies reports preclinical data on oral COTI-2 in TNBC model

April 1, 2010

YM BioSciences expands ongoing phase I/II CYT-387 study in myelofibrosis

April 1, 2010

NexMed files IND with FDA for phase II trial of PrevOnco in hepatocellular carcinoma

April 1, 2010

Eisai submits anticancer agent eribulin for approval in Japan, U.S. and Europe

April 1, 2010

SciClone reports topline phase II data on SCV-07 for prevention of oral mucositis

April 1, 2010

Emory University claims new noscapine analogues for cancer therapy

April 1, 2010

MMRF grants awards to Intellikine and Tragara for multiple myeloma therapies

March 31, 2010

Immunovaccine Technologies begins enrollment in phase I trial of DPX-0907 cancer vaccine

March 31, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...